ID: ALA2235130

Max Phase: Preclinical

Molecular Formula: C9H9F3N2

Molecular Weight: 202.18

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  N/N=C/Cc1ccc(C(F)(F)F)cc1

Standard InChI:  InChI=1S/C9H9F3N2/c10-9(11,12)8-3-1-7(2-4-8)5-6-14-13/h1-4,6H,5,13H2/b14-6+

Standard InChI Key:  DLSDXEIVWRWPBC-MKMNVTDBSA-N

Associated Targets(Human)

Gamma-amino-N-butyrate transaminase 140 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 202.18Molecular Weight (Monoisotopic): 202.0718AlogP: 2.19#Rotatable Bonds: 2
Polar Surface Area: 38.38Molecular Species: NEUTRALHBA: 2HBD: 1
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 2.71CX LogP: 2.05CX LogD: 2.05
Aromatic Rings: 1Heavy Atoms: 14QED Weighted: 0.45Np Likeness Score: -0.66

References

1. Bansal SK, Sinha BN, Khosa RL, Olson AJ.  (2011)  Novel GABA-AT inhibitors: QSAR and docking based virtual screening of phenyl substituted -phenyl ethylidene hydrazine analogues,  20  (9): [10.1007/s00044-010-9390-6]

Source